May 18, 2026

HistoSonics gets Taiwan approval for its tumour-destroying ultrasound system as it pushes into Asia

a desk with a keyboard, pencils, and various color samples
Andy Brown / Unsplash

HistoSonics has received regulatory approval from Taiwan’s Food and Drug Administration for its Edison Histotripsy System, a non-invasive cancer treatment device that uses focused ultrasound to destroy tumours without cutting, radiation, or thermal d...